The National Institutes of Health (NIH) recently awarded a five-year, $3.8 million grant to researchers for the first long-term investigation to see if medical marijuana reduces opioid use among adults with chronic pain.
The study will use real medical cannabis from New York dispensaries, not low-quality NIDA product.
The federal grant, given to scientists at Albert Einstein College of Medicine and Montefiore Health System, could provide peer-reviewed evidence of the widespread but anecdotal phenomenon of chronic pain patients stepping down from opioid use to a safer reliance on medical cannabis to manage and alleviate their pain. Notably, the study will use real medical cannabis from licensed dispensaries in New York State, not the lower-quality “research grade” cannabis grown by federal contractors in Mississippi.
Photos Prove Government-Grown Cannabis Is Basically Ditch Weed
“There is a lack of information about the impact of medical marijuana on opioid use in those with chronic pain,” Chinazo Cunningham, associate chief of general internal medicine at Einstein and Montefiore and principal investigator on the grant, said in a media release.